Survey on BP, Lipids and Cardiovascular Risks in the Outpatient Hypertensives and Continuing Medical Education Program

Huashan Hospital1 site in 1 country21,000 target enrollmentJuly 1, 2017

ConditionsHypertension Hyperlipidemia

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Hypertension
Sponsor: Huashan Hospital
Enrollment: 21000
Locations: 1
Primary Endpoint: rate of blood pressure goal achievement
Last Updated: 7 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

To investigate the proportion, medication use and control rate of metabolic abnormalities such as dyslipidemia in outpatients with hypertension in different levels of hospitals in China. To investigate the gap between guidelines and clinical practices, and analyze the cause. we also set up a continuing medical education program to narrow the gap and the effect of the program will be estimated.

Registry

clinicaltrials.gov

Start Date

July 1, 2017

End Date

December 30, 2020

Last Updated

7 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Huashan Hospital

Responsible Party

Principal Investigator

Yong Li

associate chief of the cardiology department

Huashan Hospital

Eligibility Criteria

Inclusion Criteria

•Outpatients from departments of Cardiology, Endocrinology, Nephrology, Neurology, Geriatrics or General Internal Medicine.
•Diagnosed as hypertension. Diagnostic criteria: 1)The office BP measured at the day of visit and at least one time before that day were above the cut-off values ( ≥140 mmHg SBP and/or ≥90 mmHg DBP); 2)for patients with normal BP at the day of visit, they should have already been given pre-treatment with antihypertensive drugs ≥ 2 weeks.
•Voluntary participation.

Exclusion Criteria

•Patients aged\< 18 years old.
•Patients without a definite diagnosis of hypertension（for instance, if the patient has been taking antihypertensive drugs irregularly, it is difficult to confirm the diagnosis of hypertension）.
•Patients with a definite diagnosis of secondary hypertension.
•Patients are diagnosed dyslipidemia with clear cause, such as nephrotic syndrome, severe hypothyroidism, terminal stage of malignancy, etc.
•Patients are diagnosed end-stage renal disease, hemodialysis, and peritoneal dialysis patients.
•Patients diagnosed with mental abnormalities who are unable to complete the questionnaire.
•Patients have once participated in this research during this study cycle（to avoid repeated participation）.